Pathologic fracture - Primary malignant bone tumors

Retrospective analysis of 30 patients with pathological fracture out of 336 patients with primary malignant bone tumors should demonstrate the influen ce a pathologic fracture and the form of surgical therapy have on the survi val rate. In 25 out of 30 patients a fracture led to diagnosis of the disea se. Pathological fractures occurred cumulatively by malignant fibrous histi ocytoma of the bone and in tumor stages IIb and III. Surgery was performed on 26 out of 30 patients (12 ablative therapies, 14 reconstructive therapie s). The mortality risk for patients with pathological fractures was more th an double the risk for patients without pathological fractures (P = 0.0062) , When performed correctly, reconstructive therapy does not influence the s urvival rate.